Aflunov

influenza vaccine, surface antigens haemagglutinin and neuraminidase of an H5N1-like strain (NIBRG-23) · Seqirus S.r.l.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Aflunov, covering 2008-06-16 to 2026-01-20. Get the full timeline:

Most recent: EMA Authorised: Aflunov (influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: A/turkey/Turkey/1/05 (H5N1)-like strain (NIBRG-23)) — Seqirus S.r.l.

See pricing